Last Build Date: Tue, 17 Jan 2017 17:20:52 GMTCopyright: Copyright:(C)2017 Bennett Coleman & Co. Ltd, http://info.indiatimes.com/terms/tou.html
Fri, 16 Dec 2016 19:35:12 GMT(image) CDSCO has done away with the need for joint inspections to issue licences to allow such companies to make biologic products for testing and analysis purposes.
Thu, 04 Aug 2016 10:45:14 GMT(image) The firm counts domestic private equity fund ICICI Ventures, International Finance Corp, the global investment arm of the World Bank and Subhkam Ventures as its investors.
Thu, 21 Jul 2016 16:00:38 GMT(image) Mylan and Biocon, who co-developed the proposed biosimilar, received EMA's acceptance of the submission for review, Biocon said in a statement.
Fri, 15 Jul 2016 14:49:06 GMT(image) Bayer had raised its all-cash offer to Monsanto shareholders from $ 122 to $ 125/share. It also offered a $ 1.5-billion reverse anti-trust break fee.
Fri, 15 Jul 2016 07:19:24 GMT(image) In March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.
Thu, 07 Jul 2016 12:25:34 GMT(image) Biotechnology Dept of the State has already taken up an elaborate scheme to not only tie up with other departments like Agriculture, Fisheries and Food Processing.
Thu, 23 Jun 2016 07:08:50 GMT(image) Biocon Chairperson Kiran Mazumdar Shaw said, "India has a significant number of NAION patients and we are pleased to be the first one to provide this therapy."
Mon, 20 Jun 2016 16:58:13 GMT(image) Biotech regulator GEAC today deferred its decision on commercial cultivation of genetically modified (GM) mustard in the country.
Tue, 07 Jun 2016 01:48:20 GMT(image) DBT is looking to invest in a programme to expand the existing centres for drug and vaccine research which will take up the possibility of investing.
Mon, 30 May 2016 08:42:52 GMT(image) The company's goal is to globalise Stempeucel for Buerger's Disease and the market size is approximately $ 1.5 billion worldwide.
Mon, 23 May 2016 16:06:00 GMT(image) In an order last week, the farm ministry said any company providing any new, advanced variety of GM cotton would not be allowed to charge royalties.
Sat, 21 May 2016 05:23:20 GMT(image) The move will cap royalties for any new variety that the market's sole supplier - US-based Monsanto Co - decides to develop and sell.
Fri, 29 Apr 2016 10:27:30 GMT(image) The project will identify genetic markers for cane yield, sugar content, drought tolerance and red rot resistance, in sugarcane varieties.
Mon, 28 Mar 2016 10:35:44 GMT(image) Biocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country.
Thu, 17 Mar 2016 06:19:19 GMT(image) Biocon said it has entered into a co-development and commercialization alliance with PiSA of Mexico for recombinant human insulin aimed at the US market.